The Breast Cancer Channel

Explore the latest updates, including expert interviews and features

The Breast Cancer Channel on VJOncology is supported by Gilead. These supporters have no influence over the production of the content.

Latest Videos Topics Subtype Breast Cancer Sessions Conferences Features Podcasts ESMO Breast 2022 Editorial Board

Welcome to the Breast Cancer Channel!

VJOncology brings you the latest updates in the field of breast cancer, keeping you up-to-date with the most exciting developments with video interviews, podcasts, and roundtable discussions, and more.

Reporting from key international congresses alongside our expert Editorial Board, catch up on the key advances in breast cancer, including the use of novel treatment approaches, key trial updates as well as the emerging role of treatment de-escalation.

Breast Cancer Videos by Topic

Immuno-Oncology
Surgery
Trial Updates
Molecular Profiling
Screening
0:44
ADCs in early breast cancer
Sung-Bae Kim • 11 May 2023
1:23
Latest advances in immuno-oncology research in ER+ breast cancer
Justin Balko • 12 May 2023
0:55
Prognostic biomarkers of immunotherapy efficacy in breast cancer
Justin Balko • 12 May 2023
3:55
Is it possible to predict who will benefit the most from IO in TNBC?
Justin Balko • 12 May 2023
View All Videos
5:35
EU Cancer Plan and what it means for prostate cancer
Tit Albreht • 29 Mar 2023
0:57
Highlights from St. Gallen BCC 2023
Lisa Carey • 17 Mar 2023
0:57
Role of axillary dissection in breast cancer
Eun-Sook Lee • 17 Mar 2023
1:40
Controversies and uncertainties in the surgical management of breast cancer
Eun-Sook Lee • 17 Mar 2023
View All Videos
3:24
What to look forward to in breast cancer at ASCO 2023
Hope Rugo • 12 May 2023
1:22
HER2DX risk-score in early-stage HER2-positive breast cancer
Guillermo Villacampa Javierre • 12 May 2023
6:33
Detailed safety analysis from the DESTINY-Breast04 trial
Hope Rugo • 12 May 2023
1:49
Phase Ib data CAPItello-292: capivasertib + palbociclib + fulvestrant in HR+/HER2- breast cancer
Patrick Neven • 11 May 2023
View All Videos
1:17
ILC: a commonly overlooked subtype of breast cancer
Karen Van Baelen • 12 May 2023
0:41
Investigating the influence of HER2 low status in LBC
Karen Van Baelen • 12 May 2023
1:11
Development of antibody-drug conjugate therapies in breast cancer
Heather McArthur • 12 May 2023
1:22
HER2DX risk-score in early-stage HER2-positive breast cancer
Guillermo Villacampa Javierre • 12 May 2023
View All Videos
1:23
Latest advances in immuno-oncology research in ER+ breast cancer
Justin Balko • 12 May 2023
3:55
Is it possible to predict who will benefit the most from IO in TNBC?
Justin Balko • 12 May 2023
0:37
Improving breast cancer outcomes with NGS sequencing
Paraic Kenny • 16 Apr 2023
5:35
EU Cancer Plan and what it means for prostate cancer
Tit Albreht • 29 Mar 2023
View All Videos

Breast Cancer Videos by Conference

SABCS 2022
ASCO 2022
ESMO Breast 2022
SABCS 2021
ESMO 2021
ASCO 2021
1:08
4-year MonarchE results: increasing benefits with abemaciclib + ET for ER+/HER2- high-risk early BC
Patrick Neven • 12 Dec 2022
1:17
Key trial updates in SERDs in ER+/HER2- breast cancer from SABCs 2022
Patrick Neven • 12 Dec 2022
1:02
Results of EMBER-2: imlunestrant two weeks prior to surgery for ER+/HER2- early stage breast cancer
Patrick Neven • 12 Dec 2022
0:51
EMBER-2: preoperative imlunestrant for ER+/HER2- early stage breast cancer
Patrick Neven • 12 Dec 2022
View All Videos
3:01
Assessing elacestrant in ctDNA-positive patients with ER+ breast cancer
Thomas Meyskens • 30 May 2022
4:29
Pertuzumab, trastuzumab and cyclophosphamide in older patients with HER2+ breast cancer
Thomas Meyskens • 30 May 2022
2:35
AMEERA-6: Amcenestrant, a novel SERD, in HR+ breast cancer
Thomas Meyskens • 30 May 2022
1:08
DESTINY-Breast04: A ground-breaking trial in HER2-low breast cancer
Thomas Meyskens • 30 May 2022
View All Videos
0:31
Exciting developments in ADCs for BC presented at ESMO Breast 2022
Rupert Bartsch • 5 May 2022
1:23
Exploring myeloid cells to reverse the hormone-mediated microenvironemnt of luminal breast cancer
Céline Blaye • 4 May 2022
0:27
Immunotherapy insights from ESMO Breast 2022
Céline Blaye • 4 May 2022
1:27
PRADA: evaluating radiotherapy before deep inferior flap reconstruction
Philip Poortmans • 3 May 2022
View All Videos
3:44
Correlation of Trop-2 expression with clinicopathological characteristics and outcome in TNBC
Hava Izci • 10 Dec 2021
3:50
The role of SOFT and TEXT in treatment decision making for patients with breast cancer
Meredith M. Regan • 12 Dec 2021
2:01
ASCENT: sacituzumab govitecan outperforms chemo in Black patients with TNBC
Lisa A. Carey • 7 Dec 2021
6:54
Key clinical trials investigating immunotherapy in HER2+ and HR+ breast cancer
Giuseppe Curigliano • 9 Dec 2021
View All Videos
2:06
NGS multi-panel gene testing for newly diagnosed patients with metastatic breast cancer
Evandro de Azambuja • 18 Sep 2021
4:40
AMEERA-1 updates: amcenestrant plus palbociclib for patients with ER+/HER2– advanced breast cancer
Mario Campone • 30 Sep 2021
2:46
Prognostic impact of immune interactions in patients with HER2+ and TNBC with brain metastases
Gaia Griguolo • 21 Sep 2021
2:38
HER2+ and TNBC highlights from ESMO 2021
Gaia Griguolo • 21 Sep 2021
View All Videos
1:30
Results of the Phase II GeparNuevo trial
Evandro de Azambuja • 11 Jun 2021
3:01
Top news in breast cancer from ASCO 2021
Nadia Harbeck • 7 Jun 2021
2:58
OlympiA: adjuvant olaparib following chemo significantly improves IDFS
Evandro de Azambuja • 11 Jun 2021
4:03
Phase I/II trial of zenocutuzumab for tumors with NRG1 fusions
Alison M. Schram • 4 Jun 2021
View All Videos

The Breast Cancer Channel on VJOncology is supported by Gilead.

These supporters have no influence over the production of the content.

If you are interested in becoming a supporter of The Breast Cancer Channel, please contact us.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter

Subscribe now
The content of VJOncology is intended for healthcare professionals